MAFTIVIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 10:14:13 GMT 2023` Edited by `admin` on `Sat Dec 16 10:14:13 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	KOP95331M4
Record Status	`Validated (UNII)`
Record Version

Download

Related Record	Type

Name

Type

Language

MAFTIVIMAB

Official Name

English

REGN3479

Code

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(ZAIRE EBOLAVIRUS (ZAIRE EBOLA VIRUS (EBOV)) GLYCOPROTEIN), HOMO SAPIENS MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN HOMO SAPIENS (1-448) (VH (HOMO SAPIENS IGHV3-23*04 (95.9%)-(IGHD)-IGHJ3*02(93.3%)) (8.8.11) (1-118)-HOMO SAPIENS

Systematic Name

English

MAFTIVIMAB [USAN]

Common Name

English

maftivimab [INN]

Common Name

English

REGN-EB3 COMPONENT MAFTIVIMAB

Common Name

English

Maftivimab [WHO-DD]

Common Name

English

IMMUNOGLOBULIN G1, ANTI-(ZAIRE EBOLAVIRUS GLYCOPROTEIN) (HUMAN MONOCLONAL REGN3479 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN3479 .KAPPA.-CHAIN, DIMER

Systematic Name

English

REGN-3479

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

536316

Created by admin on Sat Dec 16 10:14:13 GMT 2023 , Edited by admin on Sat Dec 16 10:14:13 GMT 2023

FDA ORPHAN DRUG

714619

Created by admin on Sat Dec 16 10:14:13 GMT 2023 , Edited by admin on Sat Dec 16 10:14:13 GMT 2023

Code System Code Type Description

USAN

EF-103

Created by admin on Sat Dec 16 10:14:13 GMT 2023 , Edited by admin on Sat Dec 16 10:14:13 GMT 2023

PRIMARY

RXCUI

2461339

Created by admin on Sat Dec 16 10:14:13 GMT 2023 , Edited by admin on Sat Dec 16 10:14:13 GMT 2023

PRIMARY

CAS

2135632-36-7

Created by admin on Sat Dec 16 10:14:13 GMT 2023 , Edited by admin on Sat Dec 16 10:14:13 GMT 2023

PRIMARY

WIKIPEDIA

Maftivimab

Created by admin on Sat Dec 16 10:14:13 GMT 2023 , Edited by admin on Sat Dec 16 10:14:13 GMT 2023

PRIMARY

DAILYMED

KOP95331M4

Created by admin on Sat Dec 16 10:14:13 GMT 2023 , Edited by admin on Sat Dec 16 10:14:13 GMT 2023

PRIMARY

INN

11034

Created by admin on Sat Dec 16 10:14:13 GMT 2023 , Edited by admin on Sat Dec 16 10:14:13 GMT 2023

PRIMARY

FDA UNII

KOP95331M4

Created by admin on Sat Dec 16 10:14:13 GMT 2023 , Edited by admin on Sat Dec 16 10:14:13 GMT 2023

PRIMARY

NCI_THESAURUS

C170146

Created by admin on Sat Dec 16 10:14:13 GMT 2023 , Edited by admin on Sat Dec 16 10:14:13 GMT 2023

PRIMARY

From	To
1_22	1_96
1_145	1_201
1_262	1_322
1_368	1_426
2_22	2_96
2_145	2_201
2_262	2_322
2_368	2_426
3_23	3_88
3_133	3_193
1_221	3_213
4_23	4_88
4_133	4_193
2_221	4_213
1_227	2_227
1_230	2_230

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_298
N	2_298

Related Record Type Details


					3R8G5WNW24

ZAIRE EBOLAVIRUS

TARGET ORGANISM->INHIBITOR

Amount:

MAFTIVIMAB-EBGN

SUB_CONCEPT->SUBSTANCE

Amount:

Related Record Type Details


					KOP95331M4

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL